- Global Pharma News & Resources

$13.2 Billion Cell-based Assay Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023 -

The "Cell-based Assay Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023" report has been added to's offering.

The global cell-based assay market reached a value of around US$ 13.2 Billion in 2017.

The market is currently being catalysed by a number of factors, this includes rising investments in research and development, adoption of high throughput screening methods, increasing prevalence of various chronic diseases, growth in drug discovery activities, and the various advantages that cell-based assays offer over alternative technologies.

The market value is further expected to reach US$ 21.1 Billion by 2023, exhibiting a CAGR of around 8% during 2018-2023.

There has been a significant increase in R&D funding by various public and private organisations so as to develop better and safer drugs. Moreover, technological advancements in cell-based assays have enabled researchers to start using this technology for drug discovery and toxicology studies.

Another major factor catalysing the growth of the market is the rising prevalence of lifestyle diseases such as arthritis, diabetes, epilepsy, cancer, cardiovascular diseases, etc. which still have large unmet needs and have led to continuous investments in R&D.

In addition, an increase in the adoption of the cell-based assay techniques for high throughput screening methods like toxicity studies, drug screening, in vitro testing, etc. are further driving this market.

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Cell-Based Assay Market

6 Market Breakup by Product and Services

7 Market Breakup by Technology

8 Market Breakup by Application

9 Market Breakup by End-User

10 Market Breakup by Region

11 Competitive Landscape

  • Becton Dickinson
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • General Electric Company
  • Merck KGaA
  • Perkinelmer, Inc.
  • Charles River Laboratories, Inc.
  • Lonza Group Ltd.
  • Cell Signaling Technology, Inc.
  • Promega Corporation
  • Cisbio Bioassays
  • Cell Biolabs, Inc.
  • Discoverx Corporation
  • Bio-Rad Laboratories, Inc.
  • Corning, Inc.
  • Hoffmann-La Roche Ltd

For more information about this report visit

View source version on

Editor Details

Last Updated: 06-Nov-2018